Regional Cancer Care Associates, Central Jersey Division — East Brunswick, New Jersey

Regional Cancer Care Associates, Central Jersey Division is a clinical research site located in East Brunswick, New Jersey, United States 08816.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Regional Cancer Care Associates, Central Jersey Division has participated in 3 clinical trials.

Therapeutic areas: Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), Small-Cell Lung Cancer (SCLC).

Sponsors: Endocyte, Genentech, Inc., Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in East Brunswick

Browse all research sites in New Jersey · View every site in East Brunswick

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Regional Cancer Care Associates, Central Jersey Division?

Regional Cancer Care Associates, Central Jersey Division has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Regional Cancer Care Associates, Central Jersey Division conducted?

Regional Cancer Care Associates, Central Jersey Division has 3 clinical trials on record. Their work covers Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), Small-Cell Lung Cancer (SCLC).

Is Regional Cancer Care Associates, Central Jersey Division accredited by Crixeo Clinical Trials?

Regional Cancer Care Associates, Central Jersey Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Regional Cancer Care Associates, Central Jersey Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.